Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue

Cancer Letters

Volumn 312, Issue 1, 2011, Pages 62-72

  Lysaght, J ^a   van der Stok, E P ^a   Allott, E H ^a   Casey, R ^a   Donohoe, C L ^a   Howard, J M ^a   McGarrigle, S A ^a   Ravi, N ^a   Reynolds, J V ^a   Pidgeon, G P ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Central obesity; Gastro intestinal malignancy; Inflammation; Tumour cell proliferation; Visceral adipose tissue

Indexed keywords

ADIPONECTIN; CD8 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; BODY MASS; CANCER CELL; CANCER INCIDENCE; CANCER MORTALITY; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NATURAL KILLER CELL; OBESITY; PRIORITY JOURNAL; STOMACH CANCER; SUBCUTANEOUS FAT; TUMOR GROWTH; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CELL GROWTH PROCESSES; FEMALE; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053319523     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.034     Document Type: Article

References (38)

1. Bray G.A. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 89:2583-2589.
2. The World Cancer Report - the major findings Cent. Eur. J. Public Health 2003, 11:177-179.
3. Ryan A.M., Rowley S.P., Fitzgerald A.P., Ravi N., Reynolds J.V. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur. J. Cancer 2006, 42:1151-1158.
4. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
5. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007, 335:1134.
6. Bessonova L., Marshall S.F., Ziogas A., Largent J., Bernstein L., Henderson K.D., Ma H., West D.W., Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int. J. Cancer 2011.
7. Berrington de Gonzalez A., Hartge P., Cerhan J.R., Flint A.J., Hannan L., MacInnis R.J., Moore S.C., Tobias G.S., Anton-Culver H., Freeman L.B., Beeson W.L., Clipp S.L., English D.R., Folsom A.R., Freedman D.M., Giles G., Hakansson N., Henderson K.D., Hoffman-Bolton J., Hoppin J.A., Koenig K.L., Lee I.M., Linet M.S., Park Y., Pocobelli G., Schatzkin A., Sesso H.D., Weiderpass E., Willcox B.J., Wolk A., Zeleniuch-Jacquotte A., Willett W.C., Thun M.J. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010, 363:2211-2219.
8. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 2005, 184:285-293.
9. Bulcao C., Ferreira S.R., Giuffrida F.M., Ribeiro-Filho F.F. The new adipose tissue and adipocytokines. Curr. Diab. Rev. 2006, 2:19-28.
10. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
11. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11:11-18.
12. Stattin P., Lukanova A., Biessy C., Soderberg S., Palmqvist R., Kaaks R., Olsson T., Jellum E. Obesity and colon cancer: does leptin provide a link?. Int. J. Cancer 2004, 109:149-152.
13. Stattin P., Palmqvist R., Soderberg S., Biessy C., Ardnor B., Hallmans G., Kaaks R., Olsson T. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol. Rep. 2003, 10:2015-2021.
14. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
15. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 2006, 23:469-480.
16. Baumgartner R.N., Heymsfield S.B., Roche A.F., Bernardino M. Abdominal composition quantified by computed tomography. Am. J. Clin. Nutr. 1988, 48:936-945.
17. Fried S.K., Moustaid-Moussa N. Culture of adipose tissue and isolated adipocytes. Methods Mol. Biol. 2001, 155:197-212.
18. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 2003, 348:1625-1638.
19. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc. Nutr. Soc. 2005, 64:163-169.
20. Trujillo M.E., Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 2006, 27:762-778.
21. Pischon T., Lahmann P.H., Boeing H., Friedenreich C., Norat T., Tjonneland A., Halkjaer J., Overvad K., Clavel-Chapelon F., Boutron-Ruault M.C., Guernec G., Bergmann M.M., Linseisen J., Becker N., Trichopoulou A., Trichopoulos D., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P.H., Bueno-de-Mesquita H.B., Boshuizen H.C., Van Guelpen B., Palmqvist R., Berglund G., Gonzalez C.A., Dorronsoro M., Barricarte A., Navarro C., Martinez C., Quiros J.R., Roddam A., Allen N., Bingham S., Khaw K.T., Ferrari P., Kaaks R., Slimani N., Riboli E. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 2006, 98:920-931.
22. Moore L.L., Bradlee M.L., Singer M.R., Splansky G.L., Proctor M.H., Ellison R.C., Kreger B.E. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int. J. Obes. Relat. Metab. Disord. 2004, 28:559-567.
23. Montague C.T., Prins J.B., Sanders L., Zhang J., Sewter C.P., Digby J., Byrne C.D., O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998, 47:1384-1391.
24. Moses A.G., Dowidar N., Holloway B., Waddell I., Fearon K.C., Ross J.A. Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients. Br. J. Surg. 2001, 88:588-593.
25. Howard J.M., Pidgeon G.P., Reynolds J.V. Leptin and gastro-intestinal malignancies. Obes. Rev. 2010, 11:863-874.
26. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 2006, 74:443-477.
27. Ferrara N. VEGF-A: a critical regulator of blood vessel growth. Eur. Cytokine Netw. 2009, 20:158-163.
28. Gerber S.A., Rybalko V.Y., Bigelow C.E., Lugade A.A., Foster T.H., Frelinger J.G., Lord E.M. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am. J. Pathol. 2006, 169:1739-1752.
29. Fujiwara H., Saga Y., Takahashi K., Ohwada M., Enomoto A., Konno R., Tanaka A., Suzuki M. Omental metastases in clinical stage I endometrioid adenocarcinoma. Int. J. Gynecol. Cancer 2008, 18:165-167.
30. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003, 46:1483-1488.
31. Donohoe C.L., Pidgeon G.P., Lysaght J., Reynolds J.V. Obesity and gastrointestinal cancer. Br. J. Surg. 2010, 97:628-642.
32. Lynch L., O'Shea D., Winter D.C., Geoghegan J., Doherty D.G., O'Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 2009, 39:1893-1901.
33. Duffaut C., Zakaroff-Girard A., Bourlier V., Decaunes P., Maumus M., Chiotasso P., Sengenes C., Lafontan M., Galitzky J., Bouloumie A. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1608-1614.
34. Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy V., Leneveu M.C., Pecquery R., Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 2002, 293:622-628.
35. Somasundar P., Riggs D., Jackson B., Vona-Davis L., McFadden D.W. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am. J. Surg. 2003, 186:575-578.
36. Lundell L.R. Etiology and risk factors for esophageal carcinoma. Dig. Dis. 2010, 28:641-644.
37. Chan A.T., Giovannucci E.L. Primary prevention of colorectal cancer. Gastroenterology 2010, 138:2029-2043. (e2010).
38. Guiu B., Petit J.M., Bonnetain F., Ladoire S., Guiu S., Cercueil J.P., Krause D., Hillon P., Borg C., Chauffert B., Ghiringhelli F. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 2010, 59:341-347.